Arrowhead (ARWR) is up 9.0%, or $4.21 to $51.00.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Arrowhead price target raised to $48 from $45 at Morgan Stanley
- Arrowhead Pharmaceuticals: Promising Growth with Redemplo Launch and Strategic Developments in Obesity Treatments
- Arrowhead Pharmaceuticals: Hold Rating Amid Redemplo Launch and Financial Stability
- Arrowhead Pharmaceuticals Reports Transformative Year-End Results
- Arrowhead reports FY25 EPS (1c), consensus (3c)